| 2026-06-02 |
详情>>
内部人交易：
Shan Hua等共交易6笔
|
| 2026-04-30 |
详情>>
业绩披露：
2026年一季报每股收益-0.01美元,归母净利润-164万美元,同比去年增长78.75%
|
| 2026-04-30 |
财报披露：
美东时间 2026-04-30 盘后发布财报
|
| 2026-04-22 |
股东大会：
将于2026-06-02召开股东大会
会议内容 ▼▲
- 1.The election of the two nominees for director named in the Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders.
2.The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement.
3.The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement.
4.The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.
|
| 2026-04-22 |
详情>>
股本变动：
变动后总股本20036.90万股
|
| 2026-03-02 |
详情>>
业绩披露：
2025年年报每股收益-0.08美元,归母净利润-1562.7万美元,同比去年增长25.29%
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.07美元,归母净利润-1344.3万美元,同比去年增长26.93%
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益-0.07美元,归母净利润-1342.4万美元,同比去年增长13.19%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益-0.04美元,归母净利润-771.7万美元,同比去年增长20.34%
|
| 2025-04-23 |
股东大会：
将于2025-06-03召开股东大会
会议内容 ▼▲
- 1.The election of the two nominees for director named in the accompanying Proxy Statement, to hold office until the 2028 Annual Meeting of Stockholders;
2.The approval of an amendment and restatement of the Company’s 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by ten million shares;
3.The approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the accompanying Proxy Statement;
4.The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025;
5.Such other business as may be properly brought before the Annual Meeting.
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益-0.11美元,归母净利润-2091.8万美元,同比去年增长44.20%
|
| 2024-10-31 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.1美元,归母净利润-1839.7万美元,同比去年增长49.12%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-0.08美元,归母净利润-1546.3万美元,同比去年增长46.48%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益-0.05美元,归母净利润-968.8万美元,同比去年增长37.97%
|
| 2024-04-26 |
股东大会：
将于2024-06-05召开股东大会
会议内容 ▼▲
- 1.The election of the three nominees for director named in the accompanying Proxy Statement, to hold office until the 2027 Annual Meeting of Stockholders.
2.The approval of the Company’s 2024 Equity Incentive Plan.
3.The approval of an amendment and restatement of the Company’s Amended and Restated Employee Stock Purchase Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 2 million shares.
4.The approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the accompanying Proxy Statement.
5.The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
6.Such other business as may be properly brought before the Annual Meeting.
|
| 2024-03-19 |
复牌提示：
2024-03-19 07:55:00 停牌，复牌日期 2024-03-19 08:30:00
|
| 2024-03-05 |
详情>>
业绩披露：
2023年年报每股收益-0.21美元,归母净利润-3748.9万美元,同比去年增长12.37%
|
| 2023-04-28 |
股东大会：
将于2023-06-07召开股东大会
会议内容 ▼▲
- 1.The election of the three nominees for director named in the accompanying Proxy Statement, to hold office until the 2026 Annual Meeting of Stockholders;
2.The approval of an amendment and restatement of the Company’s Amended and Restated 2008 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 7,000,000 shares and to make certain other changes thereto as described further in the accompanying Proxy Statement;
3.The approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the accompanying Proxy Statement;
4.The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023;
5.Such other business as may be properly brought before the Annual Meeting.
|
| 2022-04-22 |
股东大会：
将于2022-06-01召开股东大会
会议内容 ▼▲
- 1.the election of the two nominees for director named in the accompanying Proxy Statement, to hold office until the 2025 Annual Meeting of Stockholders;
2.the approval of an amendment and restatement of the Company’s Amended and Restated 2008 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 12,000,000 shares and to make certain other changes thereto as described further in the accompanying Proxy Statement;
3.the approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the accompanying Proxy Statement;
4.the indication, on an advisory basis, of the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers;
5.the ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022;
6.such other business as may be properly brought before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-23 |
股东大会：
将于2021-06-02召开股东大会
会议内容 ▼▲
- 1.the election of the three nominees for director named in the accompanying Proxy Statement, to hold office until the 2024 Annual Meeting of Stockholders;
2.the approval of a certificate of amendment of the Company’s Amended and Restated Certificate of Incorporation, as amended, to increase the total number of authorized shares of common stock from 225,000,000 shares to 400,000,000 shares;
3.the approval of an amendment and restatement of the Company’s Amended and Restated 2008 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 7,600,000 shares and to make certain other changes thereto as described further in the accompanying Proxy Statement;
4.the approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the accompanying Proxy Statement;
5.the ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021;
6.such other business as may be properly brought before the Annual Meeting.
|
| 2020-04-24 |
股东大会：
将于2020-06-03召开股东大会
会议内容 ▼▲
- 1.the election of the three nominees for director named in the accompanying Proxy Statement, to hold office until the 2023 Annual Meeting of Stockholders;
2.the approval of an amendment and restatement of the Company’s Amended and Restated 2008 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 5,000,000 shares and to make certain other changes thereto as described further in the accompanying Proxy Statement;
3.the approval of an amendment and restatement of the Company’s Amended and Restated 1996 Employee Stock Purchase Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 1,500,000 shares;
4.the approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the accompanying Proxy Statement;
5.the ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020;
6.such other business as may be properly brought before the Annual Meeting.
|
| 2019-04-26 |
股东大会：
将于2019-06-05召开股东大会
会议内容 ▼▲
- 1.the election of the two nominees for director named in the Proxy Statement, to hold office until the 2022 Annual Meeting of Stockholders;
2.the approval of an amendment and restatement of the Company’s Amended and Restated 2008 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 11,800,000 shares and to make certain other changes thereto as described further in the accompanying Proxy Statement;
3.the approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the accompanying Proxy Statement;
4.the ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2019;
5.such other business as may be properly brought before the Annual Meeting.
|
| 2018-04-27 |
股东大会：
将于2018-06-06召开股东大会
会议内容 ▼▲
- 1.the election of the two nominees for director named in the Proxy Statement, to hold office until the 2021 Annual Meeting of Stockholders;
2.the approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the Proxy Statement;
3.the ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2018;
4.such other business as may be properly brought before the Annual Meeting.
|
| 2017-04-28 |
股东大会：
将于2017-06-07召开股东大会
会议内容 ▼▲
- 1.the election of the three nominees for director named in the Proxy Statement, to hold office until the 2020 Annual Meeting of Stockholders;
2.the approval of an amendment and restatement of the Company’s Amended and Restated 2008 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 6,000,000 shares and to make certain other changes thereto as described further in the accompanying proxy;
3.the approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the Proxy Statement;
4.the ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2017;
5.such other business as may be properly brought before the annual meeting.
|
| 2016-04-29 |
股东大会：
将于2016-06-08召开股东大会
会议内容 ▼▲
- 1. the election of the two nominees for director named in the Proxy Statement, to hold office until the 2019 Annual Meeting of Stockholders;
2. the approval, on an advisory basis, of the compensation of the Company’s named executive officers as disclosed in the Proxy Statement;
3. the indication, on an advisory basis, of the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers;
4. the ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016;
5. such other business as may be properly brought before the annual meeting.
|